Cefalea cronica da abuso di sumatriptan: Descrizione di 9 casi

Confinia Cephalalgica

Volumn 5, Issue 1, 1996, Pages 11-15

  Relja, Giuliano ^a   Nider, Giorgio ^a   Grandi, Fabio Chiodo ^a   Koscica, Nadia ^a   Negro, Corrado ^b   Musco, Giovanni ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b INFM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE;

EID: 0029890159     PISSN: 11220279     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mathew NT, et al. Trasformed or evolutive migraine. Headache 1987; 27:102-106.
2. Andersson PG. Ergotamine headache. Headache 1975; 15:118-121.
3. Roswell AR. et al. Ergotamine induced headache in migrainous patients. Headache. 1973; 13:65-67.
4. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982; 33:335-342.
5. Isler H. Migraine treatment as a cause of chronic migraine. In: Rose F.C. Advances in Migraine Research and Therapy. New York: Raven Press 1982, 159-164.
6. Langemark M, et al. Drug abuse in migraine Patients. Pain 1984; 19:81-86.
7. Sternieri E, et al. L'abuso cronico di analgesi-ci minori in pazienti cefalalgici. In: Le Cefa-lee S.I.S.C. Editori: Manzoni G.G., Martucci N., Nappi G. C.I.C. Ed. Int. 1987; 43-49.
8. Manzoni CG et al. Uso e abuso dei farmaci sintomatici nelle cefalee essenziali. In: Le Cefalee S.I.S.C. Editori: Manzoni G.G., Martucci N., Nappi G. C.I.C. Ed. Int. 1987; 19-26.
9. Nappi G, Manzoni GC. Manuale delle Cefalee. Cluster Press 1991; 475-481.
10. Micieli G. Analgesic abuse: the hidden problem in migraine. Professional Postgraduate Services Europe Ltd. 1991.
11. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain of the international Headache Society. Cephalalgia 1988; 8(suppl. 7):1-96.
12. Relja G, et al. Study of the prevalence of headache induced by chronic substances use at our Headache Center, in conformity with IHS 1988 diagnostic criteria. Proceeding of the 1st Conference of European Headache Federation 1992; 73.
13. Agnoli A, Nappi G. Sumatriptan: agonista specifico dei recettori 5-HT1hke per il trattamento acuto dell'emicrania e della cefalea a grappolo. Confinia Cephalalgica 1991; suppl:1-75.
14. Tfelt-Hansen P. Sumatriptan for the treatment of migraine attacks - a revievv of controlled clinical trials. Cephalalgia 1993; 13:238-244.
15. Ferrari MD, Saxena PR. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 1993; 14:129-133.
16. Moskowitz MA. Neurogenic versus vascular mechanism of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992; 13:95-99.
17. Tfelt-Hansen P, Krabbe EA. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1981; 1:29-31.
18. Rapoport AM. Analgesic rebound headache. Headache 1988; 28:662-5.
19. Pini LA. et al. Studio sull'azione del fenazone sul sistema nervoso centrale: possibile modello sperimentale delle cefalee da abuso e sospensione di sostanze analgesiche. Confinia Cephalalgica 1992; 1:237-242.
20. Hering R, et al. 5HT in migraine patients with medication-induced headache. Cephalalgia 1993; 13:410-412.
21. Lacerenza M, et al. Migraine transformed in chronic daily headache by sumatriptan overuse. Ital J Neurol Sci 1993; Suppl. 7:130.
22. Osborne MJ, et al. Is there a problem with long term use of sumatriptan in acute migraine? BMJ 1994; 6291, vol. 308:113.
23. Osborne MJ, et al. Is there a problem with long term use of sumatriptan in acute migraine? BMJ 1994; 6291, vol. 308:113.
24. Kaube H, et al. Sumatriptan. BMJ Letter 6943, 1994; vol. 308:1573-4.
25. Catarci T, et al. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994; 14:374-5.